Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
405
datasets available to search
ShareScore release 0.9.0
Dataset results
405 results for “Letrozole”
Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer
ClinicalTrials.gov study NCT04191382. IPD Sharing: YES. Countries: 9. Publications: 1.
Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
ClinicalTrials.gov study NCT01698918. IPD Sharing: YES. Countries: 13. Publications: 1.
Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women
ClinicalTrials.gov study NCT01923168. IPD Sharing: UNDECIDED. Countries: 17. Publications: 1.
Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00073528. IPD Sharing: YES. Countries: 29. Publications: 6.
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progres
ClinicalTrials.gov study NCT03056755. IPD Sharing: YES. Countries: 19. Publications: 4.
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC
ClinicalTrials.gov study NCT02941926. IPD Sharing: YES. Countries: 38. Publications: 5.
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
ClinicalTrials.gov study NCT00601900. IPD Sharing: Not stated. Countries: 2. Publications: 4.
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
ClinicalTrials.gov study NCT00382070. IPD Sharing: Not stated. Countries: 3. Publications: 3.
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Can
ClinicalTrials.gov study NCT00050011. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer
ClinicalTrials.gov study NCT02520063. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
ClinicalTrials.gov study NCT01740427. IPD Sharing: YES. Countries: 18. Publications: 25.
Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer
ClinicalTrials.gov study NCT02692755. IPD Sharing: NO. Countries: 1. Publications: 28.
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
ClinicalTrials.gov study NCT00265759. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
ClinicalTrials.gov study NCT01068249. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.
ClinicalTrials.gov study NCT02010021. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
ClinicalTrials.gov study NCT01439711. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer
ClinicalTrials.gov study NCT03054363. IPD Sharing: NO. Countries: 1. Publications: 2.
Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate
ClinicalTrials.gov study NCT02600923. IPD Sharing: YES. Countries: 4. Publications: 1.
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
ClinicalTrials.gov study NCT00436917. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer
ClinicalTrials.gov study NCT00375752. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.